Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00205010 · ClinicalTrials.gov registry record
Laparoscopic Sentinel Lymph Node Localization in Operable Cervix Cancer
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 20
- Enrollment target
NCT00205010: Completed study, sponsored by University of Wisconsin, Madison.
NCT00205010 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00205010 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the feasibility, safety and efficacy of laparoscopic ovarian transposition in women less than 40 years of age with locally advanced cervical squamous cell carcinoma
Interventions
- PROCEDURE Lymphoscintigraphy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2003-10 |
| Est. Completion | 2006-06 |
What the finished NCT00205010 record still lists
NCT00205010 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Lymphoscintigraphy is the first listed.
NCT00205010 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00205010 about?
NCT00205010 is a clinical study titled "Laparoscopic Sentinel Lymph Node Localization in Operable Cervix Cancer". The purpose of this study is to evaluate the feasibility, safety and efficacy of laparoscopic ovarian transposition in women less than 40 years of age with locally advanced cervical squamous cell carcinoma
What is the current status of trial NCT00205010?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2003-10. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00205010?
The interventions under investigation include: Lymphoscintigraphy (PROCEDURE).
Who is sponsoring clinical trial NCT00205010?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia